Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

Prescient Therapeutics (ASX: PTX) has received fast-track designation from the US Food and Drug Administration for lead ...

Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...

The B.C. government announced on Monday it is ending the program that sent some patients to the U.S. for radiation therapy. The program, which began in May 2023, offered eligible patients the ...

On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the Ohio-based contract manufacturing and research hybrid has hung up its hat for good. Amplify’s ...

An­oth­er CD­MO has been hit by the slow­down of cell and gene ther­a­py R&D.

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on outcomes the biotech plans to use as co-primary endpoints in a ...

As Apartment Therapy's Executive Home Director, I head up our decorating, trends, and designer coverage. I studied Media Studies at UVa and Journalism at Columbia and have worked in media for more ...

We independently select these products—if you buy from one of our links, we may earn a commission. All prices were accurate at the time of publishing. When IKEA, the brand that renters especially love ...

As research continues to shed light on menopause and heart health, it is becoming increasingly clear that hormone therapy used to treat menopausal symptoms in younger, healthy women is not only ...

Pfizer cuts losses on near-approval hemophilia gene therapy, adding to troubled Sangamo's woes The prior two STAC-BBB deals include a $20 million upfront pact with Astellas in December 2024 and a ...